TL;DR
Get health and wellness essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A MedPage Today opinion by physician Hana Kahleova argues that antibiotic resistance in clinics is linked to routine antibiotic use in food animals, not just prescribing in hospitals. The article cites the spread of the mcr-1 resistance gene and a decline in colistin resistance after China banned its use as a feed additive; the broader scale of farm-to-human transmission and the impact of proposed changes remain complex.
A MedPage Today opinion article published October 4 argues that routine antibiotic use in food animals is an under-addressed source of drug resistance affecting human care. Physician Hana Kahleova says clinicians’ efforts to prescribe antibiotics carefully cannot, by themselves, tackle resistance generated upstream in food production; the article points to China’s colistin restrictions as evidence that policy changes can help reduce resistance.
Kahleova writes that about 70% of antibiotics considered important to human medicine in the United States are sold for use in food-producing animals. She says most are not used to treat sick livestock, but instead are given routinely to prevent illness or support production in intensive farming. The figure and characterization are presented in the opinion article; the supplied material does not provide the underlying study or its definitions.
The article describes resistant organisms and resistance genes moving beyond farms through meat, water, dust, workers and manure, eventually appearing in patient cultures. Kahleova cites the emergence of the transferable mcr-1 gene, which confers resistance to colistin, after the drug was used as a growth promoter in Chinese pig farming. She says the gene spread internationally and appeared in patient isolates on multiple continents.
Kahleova also points to China’s 2017 ban on colistin as a feed additive. According to her account, resistance declined in animals and people after the ban. The article gives no specific measurements, study design or time series for that decline, so readers cannot assess its size or how much of the change the policy caused from the supplied text alone.
Farm Use Reaches Human Medicine
The argument broadens antibiotic stewardship beyond decisions made in clinics and hospitals. If some resistant infections are linked to antibiotic use in food production, then prescribing discipline alone may not address every source of the problem. The article says resistant infections are estimated to kill about 35,000 people in the United States each year, and cites a Lancet forecast of roughly 39 million deaths worldwide from resistant infections between now and 2050. Those figures are estimates and projections, not counts of deaths directly attributed to farm antibiotic use.
Kahleova urges clinicians to discuss dietary choices and institutional food purchasing alongside farm policy. She argues that reducing demand for meat from systems reliant on routine antibiotics could lower pressure for that use. This is a proposed contribution to stewardship, not proof that an individual dietary change will prevent a particular infection or measurably reduce resistance on its own.
As an affiliate, we earn on qualifying purchases.
The Colistin Policy Example
Colistin is described in the article as a reserve antibiotic used for some infections resistant to other drugs. Its importance makes the spread of mcr-1 a particular concern: the gene can transfer between bacteria, potentially spreading resistance rather than remaining confined to one organism. The reported international spread illustrates why resistance in agriculture may matter beyond the animals receiving a drug.
The World Health Organization has urged farmers to stop routine preventive antibiotic use in animals that are not sick, according to Kahleova. She frames this as a targeted recommendation, not a call to withhold treatment from genuinely ill animals. The article argues that targeted rules can work, while also acknowledging that farm-level policy and changes in demand are separate approaches and neither replaces the other.
As an affiliate, we earn on qualifying purchases.
Limits of the Evidence Presented
The supplied opinion does not quantify how much human antibiotic resistance is attributable to food-animal use compared with other sources, including health-care settings and community transmission. It also does not provide the studies behind its 70% estimate or the reported decline in resistance after China’s colistin ban. The example supports the article’s policy argument, but the material provided does not establish that the ban alone caused all of the decline or show how the findings apply to other drugs and countries.
There is also no specific proposal, timetable or new government action announced in the article. Kahleova is making a case for broader clinician engagement, purchasing changes and professional advocacy, rather than reporting a newly adopted policy.
home water testing kits for bacteria
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Clinician and Policy Responses
Kahleova calls on clinicians to raise the connection between food production and resistance when discussing diet, and on hospitals to examine food-service contracts and purchasing. She also urges health professionals to press for farm-level restrictions through professional societies. The article does not identify a particular campaign, institution or forthcoming policy decision.
For readers, the next developments to watch are whether health systems change procurement practices, whether governments adopt or expand limits on routine preventive antibiotic use in livestock, and whether surveillance can measure resulting changes in resistance in animals and people. The opinion does not provide dates or targets for any of these steps.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the main claim of the article?
Hana Kahleova argues that routine antibiotic use in food animals contributes to resistance affecting human medicine, and that stewardship should address farm practices as well as clinical prescribing.
Does the article call for banning all antibiotics in livestock?
No. Kahleova says sick animals still need treatment. Her argument focuses on routine preventive use in animals that are not sick, consistent with the targeted recommendation she attributes to the World Health Organization.
What is mcr-1?
The article describes mcr-1 as a transferable gene that can confer resistance to colistin, an antibiotic used as a reserve option for some difficult infections. Kahleova says it emerged in connection with colistin use in Chinese pig farming and spread internationally.
What does the article say happened after China’s colistin ban?
Kahleova says resistance to colistin declined in animals and people after China banned its use as a feed additive in 2017. The supplied article text does not give the numerical size of the decline or enough study detail to independently evaluate the claim.
What remains unknown about the farm-to-clinic link?
The article does not quantify the share of human resistance attributable to animal agriculture or establish how much of the reported post-ban decline was caused by the policy. It also does not report a new regulation or a formal timeline for the changes it advocates.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
